Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anisodamine hydrobromide injection for sepsis
ChiCTR2200063969Phase 4Recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of raceanisodamine in sepsis (2 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoints: 28-day all-cause mortality, 7-day patient status and 11 more. Started Sep 2022; status: recruiting.
02
Drugs
raceanisodamine
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR2200063969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063969.